Centers of Excellence for Influenza Research and Surveillance (CEIRS)

Reagents

All reagents generated by the NIAID Centers of Excellence for Influenza Research and Surveillance under contract will be made available to the scientific communitiy by being placed into the NIAID Biodefense and Emerging Infections Research Resources Program repository (BEI resources).

The NIAID Biodefense and Emerging Infections Research Resource Program was established in FY 2003 through a contract awarded to the American Type Culture Collection in Manassas, Virginia (Contract N01-AI-30067). This contract:

1. makes unique, quality-assured reagents and resources available to the research community to investigate pathogenesis of the NIAID Category A, B and C Priority Pathogens and emerging pathogens;
2. aids in the development and evaluation of vaccine, therapeutics and diagnostics; and
3. initiates research and development to add value to the reagents and assays. In addition, the contract provides oversight of access to and use of the materials.

Additional information on the NIAID Biodefense and Emerging Infections Research Resource Program and access to the reagents generated by the NIAID Centers of Excellence can be found at http://www.beiresources.org/.

Reagents Deposited into the Repository

Available repository reagents will be posted to the site. Please check back for updates.

back to top